Atlas FDA

VITAGEL SURGICAL HEMOSTAT

FDA premarket approval P990030/S005 · decided 2004-09-13

Approval details

PMA number
P990030
Supplement
S005
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
VITAGEL SURGICAL HEMOSTAT
Generic name
Agent, absorbable hemostatic, collagen based
Applicant
Angiotech Medical Device Technologies
Date received
2004-08-23
Decision date
2004-09-13
Days to decision
21 days
Decision code
APPR
Product code
LMF
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Gainesville, FL
Statement
APPROVAL FOR A NEW TRADE NAME FOR THE DEVICE PREVIOUSLY KNOWN AS THE COSTASIS/DYNASTAT SURGICAL HEMOSTAT: THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME VITAGEL SURGICAL HEMOSTAT AND IS INDICATED FOR USE IN SURGICAL PROCEDURES (OTHER THAN IN NEUROSURGICAL AND OPHTHALMIC) AS AN ADJUNCT TO HEMOSTASIS WHEN CONTROL OF BLEEDING BY LIGATURE OR CONVENTIONAL PROCEDURES IS INEFFECTIVE OR IMPRACTICAL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.